A study of the humoral immune response of breast cancer patients to a panel of human tumor antigens identified by phage display

Chomez, 2001, An overview of the MAGE gene family with the identification of all human members of the family, Cancer Res, 61, 5544 Chen, 1997, A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening, Proc Natl Acad Sci USA, 94, 1914, 10.1073/pnas.94.5.1914 Neve, 2001, The role of overexpressed HER2 in transformation, Ann Oncol, 12, S9, 10.1093/annonc/12.suppl_1.S9 Wang, 1998, A breast and melanoma-shared tumor antigen: T cell responses to antigenic peptides translated from different open reading frames, J Immunol, 161, 3598, 10.4049/jimmunol.161.7.3596 Brockhausen, 1995, Mechanisms underlying aberrant glycosylation of MUC1 mucin in breast cancer cells, Eur J Biochem, 233, 607, 10.1111/j.1432-1033.1995.607_2.x Yanuck, 1993, A mutant p53 tumor suppressor protein is a target for peptide-induced CD8+ cytotoxic T-cells, Cancer Res, 53, 3257 Hansen, 2001, The tumor-infiltrating B cell response in medullary breast cancer is oligoclonal and directed against the autoantigen actin exposed on the surface of apoptotic cancer cells, Proc Natl Acad Sci USA, 98, 12659, 10.1073/pnas.171460798 Hansen, 2002, Translocation of an intracellular antigen to the surface of medullary breast cancer cells early in apoptosis allows for an antigen-driven antibody response elicited by tumor-infiltrating B cells, J Immunol, 169, 2701, 10.4049/jimmunol.169.5.2701 Coronella-Wood, 2003, Naturally occurring B-cell responses to breast cancer, Cancer Immunol Immunother, 52, 715, 10.1007/s00262-003-0409-4 Lake, 2000, Natural and induced human antibody response to cancer, Cancer Invest, 18, 480, 10.3109/07357900009032819 Sahin, 1997, Serological identification of human tumor antigens, Curr Opin Immunol, 9, 709, 10.1016/S0952-7915(97)80053-2 Disis, 1997, High-titer HER-2/neu protein-specific antibody can be detected in patients with early-stage breast cancer, J Clin Oncol, 15, 3363, 10.1200/JCO.1997.15.11.3363 Ben-Hur, 2002, The role of lymphocytes and macrophages in human breast tumorigenesis: an immunohistochemical and morphometric study, Anticancer Res, 22, 1231 Ben-Hur, 2002, Response of the immune system of mammary tumor-bearing rats to cyclophosphamide and soluble low-molecular mass tumor-associated antigens: the spleen and lymph nodes, Int J Mol Med, 9, 311 Steegmann, 2003, Chronic myeloid leukemia patients resistant to or intolerant of interferon alpha and subsequently treated with imatinib show reduced immunoglobulin levels and hypogammaglobulinemia, Haematologica, 88, 762 Sahin, 1995, Human neoplasms elicit multiple specific immune responses in the autologous host, Proc Natl Acad Sci USA, 92, 11810, 10.1073/pnas.92.25.11810 Chen YT. Identification of human tumor antigens by serological expression cloning: an online review on SEREX. Cancer Immun [updated 2004 Mar 10; cited 2004 Apr 1]. Available from URL: http://www.cancerimmunity.org/SEREX/ [Last accessed 2006-May 18]. Stockert, 1998, A survey of the humoral immune response of cancer patients to a panel of human tumor antigens, J Exp Med, 187, 1349, 10.1084/jem.187.8.1349 Mosolits, 1999, Autoantibodies against the tumour-associated antigen GA733-2 in patients with colorectal carcinoma, Cancer Immunol Immunother, 47, 315, 10.1007/s002620050536 Sioud, 2001, Profiling the immune response in patients with breast cancer by phage-displayed cDNA libraries, Eur J Immunol, 31, 716, 10.1002/1521-4141(200103)31:3<716::AID-IMMU716>3.0.CO;2-9 Carter, 2003, Serum antibodies to lipophilin B detected in late stage breast cancer patients, Clin Cancer Res, 9, 749 Hamanaka, 2003, Circulating anti-MUC1 IgG antibodies as a favorable prognostic factor for pancreatic cancer, Int J Cancer, 103, 97, 10.1002/ijc.10801 Yang, 2001, CML66, a broadly immunogenic tumor antigen, elicits a humoral immune response associated with remission of chronic myelogenous leukemia, Proc Natl Acad Sci USA, 98, 7492, 10.1073/pnas.131590998 Minenkova, 2003, Identification of tumor-associated antigens by screening phage-displayed human cDNA libraries with sera from tumor patients, Int J Cancer, 106, 534, 10.1002/ijc.11269 Pavoni, 2004, Identification of a panel of tumor-associated antigens from breast carcinoma cell lines, solid tumors and testis cDNA libraries displayed on lambda phage, BMC Cancer, 4, 78, 10.1186/1471-2407-4-78 Nakano, 1994, Purification of glutathione S-transferase fusion proteins as a non-degraded form by using a protease-negative E. coli strain, AD202, Nucleic Acids Res, 22, 543, 10.1093/nar/22.3.543 AJCC Cancer Staging Manual. American Joint Committee on Cancer. 6th ed. Philadelphia: Lippincott-Raven; 2002. Smith, 1988, Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase, Gene, 67, 31, 10.1016/0378-1119(88)90005-4 Chen, 2000, Cancer vaccine: identification of human tumor antigens by SEREX, Cancer J Sci Am, 3, S208 von Mensdorff-Pouilly, 1996, Humoral immune response to polymorphic epithelial mucin (MUC-1) in patients with benign and malignant breast tumours, Eur J Cancer, 32A, 1325, 10.1016/0959-8049(96)00048-2 Nakai, 1999, PSORT: a program for detecting sorting signals in proteins and predicting their subcellular localization, Trends Biochem Sci, 24, 34, 10.1016/S0968-0004(98)01336-X Seibold, 2003, Identification of a new tumor suppressor gene located at chromosome 8p2.13-22, FASEB J, 17, 1180, 10.1096/fj.02-0934fje Disis, 2000, Pre-existent immunity to the HER-2/neu oncogenic protein in patients with HER-2/neu overexpressing breast and ovarian cancer, Breast Cancer Res Treat, 62, 245, 10.1023/A:1006438507898 Bei, 1999, Immune responses to all ErbB family receptors detectable in serum of cancer patients, Oncogene, 18, 1267, 10.1038/sj.onc.1202442 Shimada, 2003, Japan p53 Antibody Research Group. Titration of serum p53 antibodies in 1085 patients with various types of malignant tumors: a multiinstitutional analysis by the Japan p53 Antibody Research Group, Cancer, 97, 682, 10.1002/cncr.11092 Tominaga, 2001, Detection of p73 antibodies in patients with various types of cancer: immunological characterization, Br J Cancer, 84, 57, 10.1054/bjoc.2000.1542